Jiming Chen
No ORCID on file
· 23 papers in corpus
· active 2014-2025
Study types
- article 16
- preprint 4
- case-report 1
- letter 1
- other 1
Condition tags
- endometriosis 15
- adenomyosis 7
- dysmenorrhea 5
- infertility 3
- die_deep_infiltrating 2
- thoracic_endometriosis 1
- endometrioma 1
Top journals
Frequent coauthors
- Wei-wei Wei 12
- Huiming Tang 11
- Zhiyong Dong 8
- Qiucheng Jia 8
- Hong Zheng 8
- Ruxia Shi 7
- Shoufeng Zhang 7
- Zhenyue Qin 6
- Wen‐Wen Zhang 6
- Bairong Xia 5
article
2025
BACKGROUND: The abdominal wall is one of the rare sites of endometriosis, and its clinical incidence is increasing year by year with the increasing cesarean section rate nowadays. METHODS: A retrospective analysis was made on patients with …
case-report
2025
Thoracic endometriosis syndrome is a rare form of endometriosis in which endometrial tissue is thought to migrate to the lungs and, with the onset of menstruation, the ectopic foci bleed, causing a range of pulmonary manifestations. In this…
article
2025
preprint
2024
preprint
2024
Abstract Objective: To establish a rat model of pharmacological ovariectomy by GnRH-a injection, and to preliminarily investigate the reproductive endocrine effects of Xiangshao granules on pharmacological ovariectomised rats. Methods: A ra…
article
2024
OBJECTIVE: To establish a rat model of pharmacological ovariectomy by GnRH-a injection and to preliminarily investigate the reproductive endocrine effects of Xiangshao granules on pharmacologically ovariectomized rats. METHODS: A rat model …
preprint
2024
Abstract Objective Screen the relevant diagnostic indicators of endometriosis, build a diagnostic model and verify it, so as to provide a scientific basis for diagnosis and differentiation.zig. Method(s) A total of 625 patients with patholo…
letter
2024
article
2024
Background: To evaluate the effect of carbohydrate antigen 125 (CA125) and CA19-9 in distinguishing stage Ⅲ and Ⅳ endometriosis from benign and malignant tumors, and to explore whether it is related to the clinical features of the disease. …
article
2023
Objective: The purpose of this review is to summarize drug selection for peri-menopausal symptoms caused by gonadotropin releasing-hormone agonist (GnRH-a) in the treatment of endometriosis. Mechanism: GnRH-a treatment often leads to low es…
article
2023
Background: Diffuse uterine leiomyomatosis is a benign disease with a low incidence rate, mainly manifested as menorrhagia and infertility. Due to its clinical manifestations similar to multiple uterine myomas or adenomyosis, it is often mi…
article
2023
Transumbilical single-port laparoscopy is widely used in gynecological surgery. However, it is rarely used in the treatment of deep infiltrating endometriosis due to its own shortcomings and the complex condition of deep infiltrating endome…
article
2023
Background: To evaluate the clinical efficacy and safety of the modified laparoscopic inverted triangle model for extended lesion resection in treating dysmenorrhea focal adenomyosis in women who have completed childbirth. Methods: A total …
other
2022
BACKGROUND AND OBJECTIVE: Adenomyosis focus resection has always been the main surgical method for patients with uterine preservation, but its curative effect and surgical method are still controversial. We improved this method on the basis…
article
2022
BACKGROUND: Endometriosis (EMS) is a relapsing and estrogen-dependent disease. For endometriosis such as deep endometriosis and ovarian endometrioid cysts, surgery is the most effective treatment. Long-term follow-up showed that the recurre…
preprint
2022
Abstract Objectives To evaluate the outcomes of women with uterine adenomyoma treated with combined modified laparoscopic adenomyomectomy and gonadotropin-releasing hormone (GnRH) agonists. Methods Between 2012 and 2016, 141 women with aden…
article
2022
Background: Adenomyosis is caused by endometrial glands and stroma invading the myometrium. It is more common in parturients after the age of 30. At present, there are many drugs for the treatment of adenomyosis, and drug treatment is also …
article
2021
Background: Endometriosis is a common, chronic gynecological disease. Laparoscopy is currently the preferred method of ovarian endometriosis. However, the safety and feasibility of laparoendoscopic single-site surgery for ovarian endometrio…
article
2021
Background: Endometriosis (EMS) is an estrogen-dependent disease, which easily recurs after operation. Gonadotropin-releasing hormone agonist (GnRH-a), an estrogen-inhibiting drug, can effectively inhibit the secretion of gonadotropin by pi…
article
2018
Deep infiltrating endometriosis (DIE) is defined by the presence of endometrial implants, fibrosis, and muscular hyperplasia below the peritoneum, invading the tissue to a depth of more than 5 mm [1]. Deep endometriosis involves, in descend…
article
2016
Background: The aim of this study was to investigate clinical efficacy and safety of Remifemin on peri-menopausal symp-toms in endometriosis patients with a post-operative GnRH-a therapy. Material/Methods: We treated 116 women who had endom…
article
2015
BACKGROUND: As a Chinese Traditional Medicine product, Kuntai capsule could improve the peri-menopausal symptoms in postmenopausal women. But it is still not clear whether Kuntai capsule has a good effect on alleviating peri-menopausal symp…
article
2014
BACKGROUND: The aim of this study was to investigate clinical efficacy and safety of Remifemin on peri-menopausal symptoms in endometriosis patients with a post-operative GnRH-a therapy. MATERIAL AND METHODS: We treated 116 women who had en…